Table 1 Clinical parameters of the patients
Parameter | CD31high (n = 7) | CD31low (n = 5) |
|---|---|---|
Age | 50 ± 10.6 | 49.8 ± 18.9 |
HbA1c | 8.64 ± 1.5 | 9.76 ± 3.1 |
Sex (Male/Female) | 3/4 (43/57%) | 3/2 (60/40%) |
Type 1 DM | 1 (14.3%) | 3 (60%) |
Type 2 DM | 6 (85.7%) | 2 (40%) |
Retinal Detachment (RD) | 4 (57.1%) | 1 (20%) |
Fibrovascular Proliferation (FVP) | 3 (42.9%) | 2 (40%) |
RD or FVP | 6 (85.7%) | 2 (40%) |
Diabetic Macular Edema | 3 (42.9%) | 4 (80%) |
Retinal Tear | 3 (42.9%) | 0 (0%) |
Preop. anti-VEGF ( < 1 month) | 3 (42.9%) | 2 (40%) |
Systemic Prednisolone/Steroids | 1 (14.3%) | 2 (40%) |
PRP or EndoLaser | 7 (100%) | 5 (100%) |
Prior surgery in sampled eye | 0 (0%) | 2 (40%) |
CEIOL or SFIOL | 4 (57.1%) | 1 (20%) |
360 retinectomy | 1 (14.3%) | 0 (0%) |
Tamponade used at end of surgery | 4 (57.1%) | 2 (40%) |
Lens Status (Phakic/Pseudophakic) | 7/0 (100/0%) | 3/2 (60/40%) |
